• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Glooko Launches Diabetes Medical Education Academy in Ireland

by Jasmine Pennic 07/13/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
glooko

What You Should Know:

– Glooko announced, in partnership with the Diabetes Technology Network (DTN)/Association of British Clinical Diabetologists (ABCD), the expansion into Ireland of Academy, the company’s online medical education program for clinicians who treat people with diabetes.

– Originally inspired after discussions with the National Health Service England (NHSE) as part of its effort to ensure all healthcare professionals learn uniformly about technology, the program will help clinicians further increase their knowledge and stay current on the ever-growing assortment of new diabetes technologies.

 Why Ireland?

Academy focuses exclusively on diabetes health technology and education. The program includes an extensive range of online courses for healthcare providers (HCPs) to increase expertise and mastery of these technologies, to help deploy them to people with diabetes. All courses are accessed through the Glooko® platform or the ABCD website.

According to the International Diabetes Federation, Ireland, with a population of just five million people, is ranked 7th in the world for diabetes-related health expenditure per person. For people with diabetes and their healthcare providers, managing the myriad technologies like glucose monitors and insulin pumps, and the data volumes accompanying these technologies is a well-established challenge. Technology tools like web-based programs, telehealth, mobile apps and remote monitoring are improving users’ accessibility and connectivity, but adoption of these innovations can be slow and complicated.

Ireland is the second country to implement Academy in Glooko’s plans to provide the program globally. Since launching in the UK in October of 2020, over 1,000 clinicians across more than 300 clinics have registered for the program, with more than 750 Continuing Professional Development (CPD) certificates awarded.

Availability

The program is available to all diabetes healthcare professionals in Ireland at no cost and was funded in part via sponsorships from global industry partners like AgaMatrix, Dexcom, Lilly, mylife Diabetescare, Novo Nordisk and Roche. Production was provided by DigiBete (DigiBete Global, Leeds, UK), which remains actively involved in Academy. The curriculum covers the majority of diabetes devices and technologies, and HCPs that complete the program will receive CPD accreditation as well as DTN UK/ABCD certification.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Dexcom, diabetes, Diabetes Management, Glooko, insulin, medical education, Novo Nordisk, Partners, Roche

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |